Rights and permissions
About this article
Cite this article
Changes to phase IIb Pivanex trial due to safety concerns. Inpharma Wkly. 1451, 17 (2004). https://doi.org/10.2165/00128413-200414510-00039
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200414510-00039